Nanomedicine: Technologies and Applications
Abstract
Nanomedicine is an innovative field that merges nanotechnology with medicine, aiming to enhance diagnosis, treatment, and prevention of diseases at the molecular level. This interdisciplinary domain leverages the unique properties of nanomaterials, such as their small size, surface reactivity, and ability to interact with biological systems in unprecedented ways. One of the core technologies in nanomedicine is the development of nanoscale drug delivery systems. These systems can improve the efficacy and specificity of therapeutic agents by targeting diseased cells while minimizing side effects. Nanocarriers, such as liposomes, dendrimers, and polymeric nanoparticles, are designed to deliver drugs directly to tumor sites, enhancing cancer treatment outcomes. Another critical application is in diagnostic imaging. Nanoparticles, such as quantum dots and magnetic nanoparticles, can serve as contrast agents, providing high-resolution images of biological tissues and enabling early disease detection. These imaging techniques are pivotal in diagnosing conditions like cancer, cardiovascular diseases, and neurodegenerative disorders. Nanomedicine also encompasses the development of biosensors for real-time monitoring of biomarkers. These sensors can detect minute concentrations of disease-related molecules in bodily fluids, facilitating early diagnosis and personalized treatment plans. Furthermore, regenerative medicine benefits from nanotechnology through the creation of scaffolds that support tissue growth and repair. These nanostructured materials can mimic the extracellular matrix, promoting cell adhesion and proliferation, crucial for tissue engineering and wound healing.
References
Zuo Y, Sun R, Del Piccolo N, Stevens MM. Microneedle-mediated nanomedicine to enhance therapeutic and diagnostic efficacy. Nano Converg. 2024;11(1):15.
Zhou Y, Xu M, Shen W, Xu Y, Shao A, Xu P, et al. Recent Advances in Nanomedicine for Ocular Fundus Neovascularization Disease Management. Adv Healthc Mater. 2024;13(17):e2304626.
Zhou Y, Li Q, Wu Y, Zhang W, Ding L, Ji C, et al. Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy. Adv Mater. 2024;36(21):e2313953.
Zhou H, Zhang Z, Mu Y, Yao H, Zhang Y, Wang DA. Harnessing Nanomedicine for Cartilage Repair: Design Considerations and Recent Advances in Biomaterials. ACS Nano. 2024;18(16):10667-87.
Zhou H, Yu CY, Wei H. Liposome-based nanomedicine for immune checkpoint blocking therapy and combinatory cancer therapy. Int J Pharm. 2024;652:123818.
Zheng X, Song X, Zhu G, Pan D, Li H, Hu J, et al. Nanomedicine Combats Drug Resistance in Lung Cancer. Adv Mater. 2024;36(3):e2308977.
Zhao G, Wang S, Nie G, Li N. Unlocking the power of nanomedicine: Cell membrane-derived biomimetic cancer nanovaccines for cancer treatment. Med. 2024;5(7):660-88.
Zhang Z, Yu C, Wu Y, Wang Z, Xu H, Yan Y, et al. Semiconducting polymer dots for multifunctional integrated nanomedicine carriers. Mater Today Bio. 2024;26:101028.
Zhang Y, Shi Y, Khan MM, Xiao F, Chen W, Tao W, et al. Ocular RNA nanomedicine: engineered delivery nanoplatforms in treating eye diseases. Trends Biotechnol. 2024.
Zhang Y, Chen X, Hu B, Zou B, Xu Y. Advancements in nanomedicine delivery systems: unraveling immune regulation strategies for tumor immunotherapy. Nanomedicine (Lond). 2024:1-20.
Zhang X, An M, Zhang J, Zhao Y, Liu Y. Nano-medicine therapy reprogramming metabolic network of tumour microenvironment: new opportunity for cancer therapies. J Drug Target. 2024;32(3):241-57.
Zhang H, Liu Y, Liu Z. Nanomedicine approaches against SARS-CoV-2 and variants. J Control Release. 2024;365:101-11.
Zachou ME, Kouloulias V, Chalkia M, Efstathopoulos E, Platoni K. The Impact of Nanomedicine on Soft Tissue Sarcoma Treated by Radiotherapy and/or Hyperthermia: A Review. Cancers (Basel). 2024;16(2).
Yin P, Liang W, Han B, Yang Y, Sun D, Qu X, et al. Hydrogel and Nanomedicine-Based Multimodal Therapeutic Strategies for Spinal Cord Injury. Small Methods. 2024;8(1):e2301173.
Yang G, Cao Y, Yang X, Cui T, Tan NZV, Lim YK, et al. Advancements in nanomedicine: Precision delivery strategies for male pelvic malignancies - Spotlight on prostate and colorectal cancer. Exp Mol Pathol. 2024;137:104904.
Yang EL, Sun ZJ. Nanomedicine Targeting Myeloid-Derived Suppressor Cells Enhances Anti-Tumor Immunity. Adv Healthc Mater. 2024;13(9):e2303294.
Yang C, Sharma K, Mow RJ, Bolay E, Srinivasan A, Merlin D. Unleashing the Potential of Oral Deliverable Nanomedicine in the Treatment of Inflammatory Bowel Disease. Cell Mol Gastroenterol Hepatol. 2024;18(2):101333.
Xu Y, Lv L, Wang Q, Yao Q, Kou L, Zhang H. Emerging application of nanomedicine-based therapy in acute respiratory distress syndrome. Colloids Surf B Biointerfaces. 2024;237:113869.
Wang J, Liu G, Zhou C, Cui X, Wang W, Wang J, et al. Application of artificial intelligence in cancer diagnosis and tumor nanomedicine. Nanoscale. 2024.
Walweel N, Aydin O. Enhancing Therapeutic Efficacy in Cancer Treatment: Integrating Nanomedicine with Autophagy Inhibition Strategies. ACS Omega. 2024;9(26):27832-52.
Verma R, Rao L, Nagpal D, Yadav M, Kumar M, Mittal V, et al. Exploring the Prospective of Curcumin-loaded Nanomedicine in Brain Cancer Therapy: An Overview of Recent Updates and Patented Nanoformulations. Recent Pat Nanotechnol. 2024;18(3):278-94.
Varshney M, Bahadur S. Comprehensive Review on Phytoconstituents-based Nanomedicine for the Treatment of Atopic Dermatitis. Curr Pharm Biotechnol. 2024;25(6):737-56.
Trencsényi G, Csikos C, Képes Z. Targeted Radium Alpha Therapy in the Era of Nanomedicine: In Vivo Results. Int J Mol Sci. 2024;25(1).
Tiwari R, Kolli M, Chauhan S, Yallapu MM. Tabletized Nanomedicine: From the Current Scenario to Developing Future Medicine. ACS Nano. 2024;18(18):11503-24.
Tian Y, Cheng T, Sun F, Zhou Y, Yuan C, Guo Z, et al. Effect of biophysical properties of tumor extracellular matrix on intratumoral fate of nanoparticles: Implications on the design of nanomedicine. Adv Colloid Interface Sci. 2024;326:103124.
Thatte AS, Billingsley MM, Weissman D, Melamed JR, Mitchell MJ. Emerging strategies for nanomedicine in autoimmunity. Adv Drug Deliv Rev. 2024;207:115194.
Synoradzki KJ, Paduszyńska N, Solnik M, Toro MD, Bilmin K, Bylina E, et al. From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma. Curr Oncol. 2024;31(2):778-800.
Svensson E, von Mentzer U, Stubelius A. Achieving Precision Healthcare through Nanomedicine and Enhanced Model Systems. ACS Mater Au. 2024;4(2):162-73.
Su Y, Liu B, Wang B, Chan L, Xiong C, Lu L, et al. Progress and Challenges in Tumor Ferroptosis Treatment Strategies: A Comprehensive Review of Metal Complexes and Nanomedicine. Small. 2024;20(25):e2310342.
Souto EB, Blanco-Llamero C, Krambeck K, Kiran NS, Yashaswini C, Postwala H, et al. Regulatory insights into nanomedicine and gene vaccine innovation: Safety assessment, challenges, and regulatory perspectives. Acta Biomater. 2024;180:1-17.
Song L, Jia K, Yang F, Wang J. Advanced Nanomedicine Approaches for Myocardial Infarction Treatment. Int J Nanomedicine. 2024;19:6399-425.
Shen X, Sheng H, Zhang Y, Dong X, Kou L, Yao Q, et al. Nanomedicine-based disulfiram and metal ion co-delivery strategies for cancer treatment. Int J Pharm X. 2024;7:100248.
Shen X, Pan D, Gong Q, Gu Z, Luo K. Enhancing drug penetration in solid tumors via nanomedicine: Evaluation models, strategies and perspectives. Bioact Mater. 2024;32:445-72.
Setia A, Challa RR, Vallamkonda B, Satti P, Mehata AK, Priya V, et al. Nanomedicine And Nanotheranostics: Special Focus on Imaging of Anticancer Drugs Induced Cardiac Toxicity. Nanotheranostics. 2024;8(4):473-96.
Sandbhor P, Palkar P, Bhat S, John G, Goda JS. Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy. Nanoscale. 2024;16(13):6330-64.
Salvati A. The biomolecular corona of nanomedicines: effects on nanomedicine outcomes and emerging opportunities. Curr Opin Biotechnol. 2024;87:103101.
Sahoo A, Dwivedi K, Almalki WH, Mandal AK, Alhamyani A, Afzal O, et al. Secondary metabolites in topical infectious diseases and nanomedicine applications. Nanomedicine (Lond). 2024.
Rehan F, Zhang M, Fang J, Greish K. Therapeutic Applications of Nanomedicine: Recent Developments and Future Perspectives. Molecules. 2024;29(9).
Prasad R, Jyothi VGS, Kommineni N, Bulusu RT, Mendes BB, Lovell JF, et al. Biomimetic Ghost Nanomedicine-Based Optotheranostics for Cancer. Nano Lett. 2024;24(27):8217-31.
Pozzi S, Satchi-Fainaro R. The role of CCL2/CCR2 axis in cancer and inflammation: The next frontier in nanomedicine. Adv Drug Deliv Rev. 2024;209:115318.
Pegoraro C, Domingo-Ortí I, Conejos-Sánchez I, Vicent MJ. Unlocking the Mitochondria for Nanomedicine-based Treatments: Overcoming Biological Barriers, Improving Designs, and Selecting Verification Techniques. Adv Drug Deliv Rev. 2024;207:115195.
Patel KD, Keskin-Erdogan Z, Sawadkar P, Nik Sharifulden NSA, Shannon MR, Patel M, et al. Oxidative stress modulating nanomaterials and their biochemical roles in nanomedicine. Nanoscale Horiz. 2024.
Patel J, Kumar GS, Roy H, Maddiboyina B, Leporatti S, Bohara RA. From nature to nanomedicine: bioengineered metallic nanoparticles bridge the gap for medical applications. Discov Nano. 2024;19(1):85.
Parvin N, Kumar V, Joo SW, Mandal TK. Emerging Trends in Nanomedicine: Carbon-Based Nanomaterials for Healthcare. Nanomaterials (Basel). 2024;14(13).
Pan S, Fan R, Han B, Tong A, Guo G. The potential of mRNA vaccines in cancer nanomedicine and immunotherapy. Trends Immunol. 2024;45(1):20-31.
Müller WEG, Neufurth M, Wang S, Schröder HC, Wang X. The Physiological Inorganic Polymers Biosilica and Polyphosphate as Key Drivers for Biomedical Materials in Regenerative Nanomedicine. Int J Nanomedicine. 2024;19:1303-37.
Mufti A, Gulati S, Kochhar KP, Alam I, Wadhwa S, Sikka K, et al. Novel Therapeutic Strategies of Non-Invasive Brain Stimulation and Nanomedicine in Pediatric Cerebral Palsy Patients. Neurol India. 2024;72(2):248-57.
Morel VJ, Rössler J, Bernasconi M. Targeted immunotherapy and nanomedicine for rhabdomyosarcoma: The way of the future. Med Res Rev. 2024.
Moghassemi S, Dadashzadeh A, Sousa MJ, Vlieghe H, Yang J, León-Félix CM, et al. Extracellular vesicles in nanomedicine and regenerative medicine: A review over the last decade. Bioact Mater. 2024;36:126-56.
Mathur P, Bhatt S, Kumar S, Kamboj S, Kamboj R, Rana A, et al. Deciphering the Therapeutic Applications of Nanomedicine in Ovarian Cancer Therapy: An Overview. Curr Drug Deliv. 2024;21(9):1180-96.
Mahjoubin-Tehran M, Rezaei S, Kesharwani P, Sahebkar A. Nanospheres for curcumin delivery as a precision nanomedicine in cancer therapy. J Biomater Sci Polym Ed. 2024:1-25.
Mahajan K, Bhattacharya S. The Advancement and Obstacles in Improving the Stability of Nanocarriers for Precision Drug Delivery in the Field of Nanomedicine. Curr Top Med Chem. 2024;24(8):686-721.
Lv Z, Li S, Zeng G, Yao K, Han H. Recent progress of nanomedicine in managing dry eye disease. Adv Ophthalmol Pract Res. 2024;4(1):23-31.
Luo Y, Liu H, Chen M, Zhang Y, Zheng W, Wu L, et al. Immunomodulatory nanomedicine for osteoporosis: Current practices and emerging prospects. Acta Biomater. 2024;179:13-35.
Lulseged BA, Ramaiyer MS, Michel R, Saad EE, Ozpolat B, Borahay MA. The Role of Nanomedicine in Benign Gynecologic Disorders. Molecules. 2024;29(9).
Lu J, Tai Z, Wu J, Li L, Zhang T, Liu J, et al. Nanomedicine-induced programmed cell death enhances tumor immunotherapy. J Adv Res. 2024;62:199-217.
López-Estévez AM, Lapuhs P, Pineiro-Alonso L, Alonso MJ. Personalized Cancer Nanomedicine: Overcoming Biological Barriers for Intracellular Delivery of Biopharmaceuticals. Adv Mater. 2024;36(14):e2309355.
Liu Y, Liu H, Guo S, Zhao Y, Qi J, Zhang R, et al. A review of carbon nanomaterials/bacterial cellulose composites for nanomedicine applications. Carbohydr Polym. 2024;323:121445.
Lin P, Lu Y, Zheng J, Lin Y, Zhao X, Cui L. Strategic disruption of cancer's powerhouse: precise nanomedicine targeting of mitochondrial metabolism. J Nanobiotechnology. 2024;22(1):318.
Zhang Y, Wang T, Sun M, Song Y, Huang X, Zhang S, et al. Advanced Nanomedicine: Redefining Therapeutic Paradigms for Inflammatory Bowel Disease. Adv Healthc Mater. 2023;12(19):e2300069.
Zhang X, Centurion F, Misra A, Patel S, Gu Z. Molecularly targeted nanomedicine enabled by inorganic nanoparticles for atherosclerosis diagnosis and treatment. Adv Drug Deliv Rev. 2023;194:114709.
Zhang P, Xiao Y, Sun X, Lin X, Koo S, Yaremenko AV, et al. Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospects. Med. 2023;4(3):147-67.
Zhang J, Sun S, Chen H, Feng Y, Li Y, Dong Z. Advances in natural compound-based nanomedicine and the interaction with gut microbiota in ulcerative colitis therapy. Front Pharmacol. 2023;14:1197144.
Zhang F, Xu Z, Jolly KJ. Myeloid cell-mediated drug delivery: From nanomedicine to cell therapy. Adv Drug Deliv Rev. 2023;197:114827.
Zhang C, Zhao J, Wang W, Geng H, Wang Y, Gao B. Current advances in the application of nanomedicine in bladder cancer. Biomed Pharmacother. 2023;157:114062.
Zeng M, Guo D, Fernández-Varo G, Zhang X, Fu S, Ju S, et al. The Integration of Nanomedicine with Traditional Chinese Medicine: Drug Delivery of Natural Products and Other Opportunities. Mol Pharm. 2023;20(2):886-904.
Zambonino MC, Quizhpe EM, Mouheb L, Rahman A, Agathos SN, Dahoumane SA. Biogenic Selenium Nanoparticles in Biomedical Sciences: Properties, Current Trends, Novel Opportunities and Emerging Challenges in Theranostic Nanomedicine. Nanomaterials (Basel). 2023;13(3).
Zahid AA, Chakraborty A, Luo W, Coyle A, Paul A. Tailoring the Inherent Properties of Biobased Nanoparticles for Nanomedicine. ACS Biomater Sci Eng. 2023;9(7):3972-86.
Yosri N, Alsharif SM, Xiao J, Musharraf SG, Zhao C, Saeed A, et al. Arctium lappa (Burdock): Insights from ethnopharmacology potential, chemical constituents, clinical studies, pharmacological utility and nanomedicine. Biomed Pharmacother. 2023;158:114104.
Yin W, Chang J, Sun J, Zhang T, Zhao Y, Li Y, et al. Nanomedicine-mediated ferroptosis targeting strategies for synergistic cancer therapy. J Mater Chem B. 2023;11(6):1171-90.
Yin L, Li H, Shi L, Chen K, Pan H, Han W. Research advances in nanomedicine applied to the systemic treatment of colorectal cancer. Int J Cancer. 2023;152(5):807-21.
Yi Y, Yu M, Li W, Zhu D, Mei L, Ou M. Vaccine-like nanomedicine for cancer immunotherapy. J Control Release. 2023;355:760-78.
Yao J, Zhang A, Qiu Y, Li Z, Wu X, Li Z, et al. Navigating zinc-involved nanomedicine in oncotherapy. Nanoscale. 2023;15(9):4261-76.
Yang Z, Gao D, Zhao J, Yang G, Guo M, Wang Y, et al. Thermal immuno-nanomedicine in cancer. Nat Rev Clin Oncol. 2023;20(2):116-34.
Yang S, Song Y, Hu Y, Chen H, Yang D, Song X. Multifaceted Roles of Copper Ions in Anticancer Nanomedicine. Adv Healthc Mater. 2023;12(23):e2300410.
Yang H, Yao X, Liu Y, Shen X, Li M, Luo Z. Ferroptosis Nanomedicine: Clinical Challenges and Opportunities for Modulating Tumor Metabolic and Immunological Landscape. ACS Nano. 2023;17(16):15328-53.
Yang F, He Q, Dai X, Zhang X, Song D. The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies. Front Pharmacol. 2023;14:1143102.
Yadav R, Das PP, Sharma S, Sengupta S, Kumar D, Sagar R. Recent advancement of nanomedicine-based targeted delivery for cervical cancer treatment. Med Oncol. 2023;40(12):347.
Xue S, Ruan G, Li J, Madry H, Zhang C, Ding C. Bio-responsive and multi-modality imaging nanomedicine for osteoarthritis theranostics. Biomater Sci. 2023;11(15):5095-107.
Xu Z, Xu Y, Zhang K, Liu Y, Liang Q, Thakur A, et al. Plant-derived extracellular vesicles (PDEVs) in nanomedicine for human disease and therapeutic modalities. J Nanobiotechnology. 2023;21(1):114.
Xu Y, Hsu JC, Xu L, Chen W, Cai W, Wang K. Nanomedicine-based adjuvant therapy: a promising solution for lung cancer. J Nanobiotechnology. 2023;21(1):211.
Xu X, Xu L, Wen C, Xia J, Zhang Y, Liang Y. Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform. Mater Today Bio. 2023;22:100760.
Xu X, Liu A, Liu S, Ma Y, Zhang X, Zhang M, et al. Application of molecular dynamics simulation in self-assembled cancer nanomedicine. Biomater Res. 2023;27(1):39.
Xu Q, Lan X, Lin H, Xi Q, Wang M, Quan X, et al. Tumor microenvironment-regulating nanomedicine design to fight multi-drug resistant tumors. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023;15(1):e1842.
Xu M, Han X, Xiong H, Gao Y, Xu B, Zhu G, et al. Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials. Molecules. 2023;28(13).
Wu R, Wang K, Gai Y, Li M, Wang J, Wang C, et al. Nanomedicine for renal cell carcinoma: imaging, treatment and beyond. J Nanobiotechnology. 2023;21(1):3.
Wu D, Chen X, Zhou S, Li B. Reactive oxidative species (ROS)-based nanomedicine for BBB crossing and glioma treatment: current status and future directions. Front Immunol. 2023;14:1241791.
Wang Z, Wang X, Chang M, Guo J, Chen Y. Ultrasound nanomedicine and materdicine. J Mater Chem B. 2023;11(24):5350-77.
Wang Z, Jin A, Yang Z, Huang W. Advanced Nitric Oxide Generating Nanomedicine for Therapeutic Applications. ACS Nano. 2023;17(10):8935-65.
Wang X, Dai X, Chen Y. Sonopiezoelectric Nanomedicine and Materdicine. Small. 2023;19(29):e2301693.
Wang Q, Atluri K, Tiwari AK, Babu RJ. Exploring the Application of Micellar Drug Delivery Systems in Cancer Nanomedicine. Pharmaceuticals (Basel). 2023;16(3).
Wang K, Mao W, Song X, Chen M, Feng W, Peng B, et al. Reactive X (where X = O, N, S, C, Cl, Br, and I) species nanomedicine. Chem Soc Rev. 2023;52(20):6957-7035.
Wang C, Wen L, Wang K, Wu R, Li M, Zhang Y, et al. Visualization of ferroptosis in brain diseases and ferroptosis-inducing nanomedicine for glioma. Am J Nucl Med Mol Imaging. 2023;13(5):179-94.
Wang C, Li Q, Xiao J, Liu Y. Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas. Cancer Biol Med. 2023;20(5):325-43.
van Strien J, Escalona-Rayo O, Jiskoot W, Slütter B, Kros A. Elastin-like polypeptide-based micelles as a promising platform in nanomedicine. J Control Release. 2023;353:713-26.
Vakhshiteh F, Bagheri Z, Soleimani M, Ahvaraki A, Pournemat P, Alavi SE, et al. Heterotypic tumor spheroids: a platform for nanomedicine evaluation. J Nanobiotechnology. 2023;21(1):249.
Urbanova M, Cihova M, Buocikova V, Slopovsky J, Dubovan P, Pindak D, et al. Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival. Biomed Pharmacother. 2023;165:115179.
Tu B, Gao Y, An X, Wang H, Huang Y. Localized delivery of nanomedicine and antibodies for combating COVID-19. Acta Pharm Sin B. 2023;13(5):1828-46.
Tramontano C, De Stefano L, Rea I. Diatom-Based Nanomedicine for Colorectal Cancer Treatment: New Approaches for Old Challenges. Mar Drugs. 2023;21(5).
Trac N, Ashraf A, Giblin J, Prakash S, Mitragotri S, Chung EJ. Spotlight on Genetic Kidney Diseases: A Call for Drug Delivery and Nanomedicine Solutions. ACS Nano. 2023;17(7):6165-77.
Tomitaka A, Vashist A, Kolishetti N, Nair M. Machine learning assisted-nanomedicine using magnetic nanoparticles for central nervous system diseases. Nanoscale Adv. 2023;5(17):4354-67.
Tian Y, Liu Z, Wang J, Li L, Wang F, Zhu Z, et al. Nanomedicine for Combination Urologic Cancer Immunotherapy. Pharmaceutics. 2023;15(2).
Thapa RK, Kim JO. Nanomedicine-based commercial formulations: current developments and future prospects. J Pharm Investig. 2023;53(1):19-33.
Teixidor F, Núñez R, Viñas C. Towards the Application of Purely Inorganic Icosahedral Boron Clusters in Emerging Nanomedicine. Molecules. 2023;28(11).
Taylor J, Sharp A, Rannard SP, Arrowsmith S, McDonald TO. Nanomedicine strategies to improve therapeutic agents for the prevention and treatment of preterm birth and future directions. Nanoscale Adv. 2023;5(7):1870-89.
Tanaka HY, Nakazawa T, Enomoto A, Masamune A, Kano MR. Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment. Cancers (Basel). 2023;15(3).
Sun Z, Li T, Mei T, Liu Y, Wu K, Le W, et al. Nanoscale MOFs in nanomedicine applications: from drug delivery to therapeutic agents. J Mater Chem B. 2023;11(15):3273-94.
Sun Y, Lian T, Huang Q, Chang Y, Li Y, Guo X, et al. Nanomedicine-mediated regulated cell death in cancer immunotherapy. J Control Release. 2023;364:174-94.
Su MC, Nethi SK, Dhanyamraju PK, Prabha S. Nanomedicine Strategies for Targeting Tumor Stroma. Cancers (Basel). 2023;15(16).
Stavrou M, Phung N, Grimm J, Andreou C. Organ-on-chip systems as a model for nanomedicine. Nanoscale. 2023;15(23):9927-40.
Srinivash M, Krishnamoorthi R, Mahalingam PU, Malaikozhundan B, Bharathakumar S, Gurushankar K, et al. Nanomedicine for drug resistant pathogens and COVID-19 using mushroom nanocomposite inspired with bacteriocin - A review. Inorg Chem Commun. 2023;152:110682.
Song X, Zhang Q, Chang M, Ding L, Huang H, Feng W, et al. Nanomedicine-Enabled Sonomechanical, Sonopiezoelectric, Sonodynamic, and Sonothermal Therapy. Adv Mater. 2023;35(31):e2212259.
Song X, Sun Z, Li L, Zhou L, Yuan S. Application of nanomedicine in radiotherapy sensitization. Front Oncol. 2023;13:1088878.
Song FX, Xu X, Ding H, Yu L, Huang H, Hao J, et al. Recent Progress in Nanomaterial-Based Biosensors and Theranostic Nanomedicine for Bladder Cancer. Biosensors (Basel). 2023;13(1).
Son H, Shin J, Park J. Recent progress in nanomedicine-mediated cytosolic delivery. RSC Adv. 2023;13(15):9788-99.
Sommonte F, Denora N, Lamprou DA. Combining 3D Printing and Microfluidic Techniques: A Powerful Synergy for Nanomedicine. Pharmaceuticals (Basel). 2023;16(1).
Solidum JGN, Ceriales JA, Ong EP, Ornos EDB, Relador RJL, Quebral EPB, et al. Nanomedicine and nanoparticle-based delivery systems in plastic and reconstructive surgery. Maxillofac Plast Reconstr Surg. 2023;45(1):15.
Smith IT, Zhang E, Yildirim YA, Campos MA, Abdel-Mottaleb M, Yildirim B, et al. Nanomedicine and nanobiotechnology applications of magnetoelectric nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023;15(2):e1849.
Singla M, Smriti, Gupta S, Behal P, Singh SK, Preetam S, et al. Unlocking the power of nanomedicine: the future of nutraceuticals in oncology treatment. Front Nutr. 2023;10:1258516.
Singh AV, Varma M, Laux P, Choudhary S, Datusalia AK, Gupta N, et al. Artificial intelligence and machine learning disciplines with the potential to improve the nanotoxicology and nanomedicine fields: a comprehensive review. Arch Toxicol. 2023;97(4):963-79.
Sharifi S, Reuel N, Kallmyer N, Sun E, Landry MP, Mahmoudi M. The Issue of Reliability and Repeatability of Analytical Measurement in Industrial and Academic Nanomedicine. ACS Nano. 2023;17(1):4-11.
Serrano-Martínez A, Victoria-Montesinos D, García-Muñoz AM, Hernández-Sánchez P, Lucas-Abellán C, González-Louzao R. A Systematic Review of Clinical Trials on the Efficacy and Safety of CRLX101 Cyclodextrin-Based Nanomedicine for Cancer Treatment. Pharmaceutics. 2023;15(7).
Schmidt TJN, Berarducci B, Konstantinidou S, Raffa V. CRISPR/Cas9 in the era of nanomedicine and synthetic biology. Drug Discov Today. 2023;28(1):103375.
Saiding Q, Zhang Z, Chen S, Xiao F, Chen Y, Li Y, et al. Nano-bio interactions in mRNA nanomedicine: Challenges and opportunities for targeted mRNA delivery. Adv Drug Deliv Rev. 2023;203:115116.
Saeed U, Insaf RA, Piracha ZZ, Tariq MN, Sohail A, Abbasi UA, et al. Crisis averted: a world united against the menace of multiple drug-resistant superbugs -pioneering anti-AMR vaccines, RNA interference, nanomedicine, CRISPR-based antimicrobials, bacteriophage therapies, and clinical artificial intelligence strategies to safeguard global antimicrobial arsenal. Front Microbiol. 2023;14:1270018.
Saeed S, Ud Din SR, Khan SU, Gul R, Kiani FA, Wahab A, et al. Nanoparticle: A Promising Player in Nanomedicine and its Theranostic Applications for the Treatment of Cardiovascular Diseases. Curr Probl Cardiol. 2023;48(5):101599.
Sa P, Sahoo SK, Dilnawaz F. Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance. Curr Med Chem. 2023;30(29):3335-55.
Sa P, Mohapatra P, Swain SS, Khuntia A, Sahoo SK. Phytochemical-Based Nanomedicine for Targeting Tumor Microenvironment and Inhibiting Cancer Chemoresistance: Recent Advances and Pharmacological Insights. Mol Pharm. 2023;20(11):5254-77.
Russell P, Esser L, Hagemeyer CE, Voelcker NH. The potential impact of nanomedicine on COVID-19-induced thrombosis. Nat Nanotechnol. 2023;18(1):11-22.
Rowlands CE, Folberg AM, Beickman ZK, Devor EJ, Leslie KK, Givens BE. Particles and Prejudice: Nanomedicine Approaches to Reducing Health Disparities in Endometrial Cancer. Small. 2023:e2300096.
Rosso G, Cauda V. Biomimicking Extracellular Vesicles with Fully Artificial Ones: A Rational Design of EV-BIOMIMETICS toward Effective Theranostic Tools in Nanomedicine. ACS Biomater Sci Eng. 2023;9(11):5924-32.
Rani A, Marsche G. A Current Update on the Role of HDL-Based Nanomedicine in Targeting Macrophages in Cardiovascular Disease. Pharmaceutics. 2023;15(5).
Ramirez-Garcia PD, Veldhuis NA, Bunnett NW, Davis TP. Targeting endosomal receptors, a new direction for polymers in nanomedicine. J Mater Chem B. 2023;11(24):5390-9.
Ramesh P, Palaniappan A. Terminalia arjuna, a Cardioprotective Herbal Medicine-Relevancy in the Modern Era of Pharmaceuticals and Green Nanomedicine-A Review. Pharmaceuticals (Basel). 2023;16(1).
Rajwar TK, Pradhan D, Halder J, Rai VK, Kar B, Ghosh G, et al. Opportunity in nanomedicine to counter the challenges of current drug delivery approaches used for the treatment of malaria: a review. J Drug Target. 2023;31(4):354-68.
Rahmanian M, Ghahremani A, Kesharwani P, Oroojalian F, Sahebkar A. Nanomedicine innovations in spinal cord injury management: Bridging the gap. Environ Res. 2023;235:116563.
Rahman M, Afzal O, Ullah S, Alshahrani MY, Alkhathami AG, Altamimi ASA, et al. Nanomedicine-Based Drug-Targeting in Breast Cancer: Pharmacokinetics, Clinical Progress, and Challenges. ACS Omega. 2023;8(51):48625-49.
Qu X, Zhou D, Lu J, Qin D, Zhou J, Liu HJ. Cancer nanomedicine in preoperative therapeutics: Nanotechnology-enabled neoadjuvant chemotherapy, radiotherapy, immunotherapy, and phototherapy. Bioact Mater. 2023;24:136-52.
Puri S, Mazza M, Roy G, England RM, Zhou L, Nourian S, et al. Evolution of nanomedicine formulations for targeted delivery and controlled release. Adv Drug Deliv Rev. 2023;200:114962.
Puranik N, Yadav D, Song M. Advancements in the Application of Nanomedicine in Alzheimer's Disease: A Therapeutic Perspective. Int J Mol Sci. 2023;24(18).
Pricl S. The Spicy Science of Dendrimers in the Realm of Cancer Nanomedicine: A Report from the COST Action CA17140 Nano2Clinic. Pharmaceutics. 2023;15(7).
Prakash S. mRNA-Based Nanomedicine: A New Strategy for Treating Infectious Diseases and Beyond. Eur J Drug Metab Pharmacokinet. 2023;48(5):515-29.
Pereira LFT, Dallagnol CA, Moulepes TH, Hirota CY, Kutsmi P, Dos Santos LV, et al. Oxygen therapy alternatives in COVID-19: From classical to nanomedicine. Heliyon. 2023;9(4):e15500.
Peng L, Xu Q, Yin S, Zhang Y, Wu H, Liu Y, et al. The emerging nanomedicine-based technology for non-small cell lung cancer immunotherapy: how far are we from an effective treatment. Front Oncol. 2023;13:1153319.
Patel P, Pal R, Butani K, Singh S, Prajapati BG. Nanomedicine-fortified cosmeceutical serums for the mitigation of psoriasis and acne. Nanomedicine (Lond). 2023;18(24):1769-93.
Pan Y, Liu L, Mou X, Cai Y. Nanomedicine Strategies in Conquering and Utilizing the Cancer Hypoxia Environment. ACS Nano. 2023;17(21):20875-924.
Overchuk M, Weersink RA, Wilson BC, Zheng G. Photodynamic and Photothermal Therapies: Synergy Opportunities for Nanomedicine. ACS Nano. 2023;17(9):7979-8003.
Nirmala MJ, Kizhuveetil U, Johnson A, G B, Nagarajan R, Muthuvijayan V. Cancer nanomedicine: a review of nano-therapeutics and challenges ahead. RSC Adv. 2023;13(13):8606-29.
Narmani A, Jahedi R, Bakhshian-Dehkordi E, Ganji S, Nemati M, Ghahramani-Asl R, et al. Biomedical applications of PLGA nanoparticles in nanomedicine: advances in drug delivery systems and cancer therapy. Expert Opin Drug Deliv. 2023;20(7):937-54.
Mohanty A, Park IK. Protein-Caged Nanoparticles: A Promising Nanomedicine Against Cancer. Chonnam Med J. 2023;59(1):1-12.
Mohamed NA, Zupin L, Mazi SI, Al-Khatib HA, Crovella S. Nanomedicine as a Potential Tool against Monkeypox. Vaccines (Basel). 2023;11(2).
Mirhadi E, Kesharwani P, Johnston TP, Sahebkar A. Nanomedicine-mediated therapeutic approaches for pulmonary arterial hypertension. Drug Discov Today. 2023;28(6):103599.
Mir Najib Ullah SN, Afzal O, Altamimi ASA, Ather H, Sultana S, Almalki WH, et al. Nanomedicine in the Management of Alzheimer's Disease: State-of-the-Art. Biomedicines. 2023;11(6).
Mehrabi MR, Soltani M, Chiani M, Raahemifar K, Farhangi A. Nanomedicine: New Frontiers in Fighting Microbial Infections. Nanomaterials (Basel). 2023;13(3).
Mehata AK, Vikas, Viswanadh MK, Muthu MS. Theranostics of metal-organic frameworks: image-guided nanomedicine for clinical translation. Nanomedicine (Lond). 2023;18(8):695-703.
Mehata AK, Setia A, Vikas, Malik AK, Hassani R, Dailah HG, et al. Vitamin E TPGS-Based Nanomedicine, Nanotheranostics, and Targeted Drug Delivery: Past, Present, and Future. Pharmaceutics. 2023;15(3).
Martins C, Sarmento B. Multi-ligand functionalized blood-to-tumor sequential targeting strategies in the field of glioblastoma nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023;15(5):e1893.
Marques C, Fernandes MH, Lima SAC. Elucidating Berberine's Therapeutic and Photosensitizer Potential through Nanomedicine Tools. Pharmaceutics. 2023;15(9).
Mao Y, Ren J, Yang L. Advances of nanomedicine in treatment of atherosclerosis and thrombosis. Environ Res. 2023;238(Pt 2):116637.
Mahmoudi M, Landry MP, Moore A, Coreas R. The protein corona from nanomedicine to environmental science. Nat Rev Mater. 2023:1-17.
Mahaling B, Low SWY, Ch S, Addi UR, Ahmad B, Connor TB, et al. Next-Generation Nanomedicine Approaches for the Management of Retinal Diseases. Pharmaceutics. 2023;15(7).
Ma GL, Lin WF. Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy. Mil Med Res. 2023;10(1):20.
Boggio E, Gigliotti CL, Stoppa I, Pantham D, Sacchetti S, Rolla R, et al. Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications. Pharmaceutics. 2023;15(3).
Bishop B, Sharma S, Scott EA. Nanomedicine in kidney disease. Curr Opin Nephrol Hypertens. 2023;32(4):366-76.
Bhattacharjee B, Syeda AF, Rynjah D, Hussain SM, Chandra Bora S, Pegu P, et al. Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment. Front Pharmacol. 2023;14:1174330.
Bhatt S, Punetha VD, Pathak R, Punetha M. Graphene in nanomedicine: A review on nano-bio factors and antibacterial activity. Colloids Surf B Biointerfaces. 2023;226:113323.
Bahadur S, Prakash A. A Comprehensive Review on Nanomedicine: Promising Approach for Treatment of Brain Tumor through Intranasal Administration. Curr Drug Targets. 2023;24(1):71-88.
Aziz T, Nadeem AA, Sarwar A, Perveen I, Hussain N, Khan AA, et al. Particle Nanoarchitectonics for Nanomedicine and Nanotherapeutic Drugs with Special Emphasis on Nasal Drugs and Aging. Biomedicines. 2023;11(2).
Ashkarran AA, Lin Z, Rana J, Bumpers H, Sempere L, Mahmoudi M. Impact of Nanomedicine in Women's Metastatic Breast Cancer. Small. 2023:e2301385.
Aryal S, Park S, Park H, Park C, Kim WC, Thakur D, et al. Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches. Int J Nanomedicine. 2023;18:7865-88.
Anwar F, Al-Abbasi FA, Naqvi S, Sheikh RA, Alhayyani S, Asseri AH, et al. Therapeutic Potential of Nanomedicine in Management of Alzheimer's Disease and Glioma. Int J Nanomedicine. 2023;18:2737-56.
Ansari JA, Malik JA, Ahmed S, Bhat FA, Khanam A, Mir SA, et al. Targeting Breast Cancer Signaling via Phytomedicine and Nanomedicine. Pharmacology. 2023;108(6):504-20.
Andre M, Nair M, Raymond AD. HIV Latency and Nanomedicine Strategies for Anti-HIV Treatment and Eradication. Biomedicines. 2023;11(2).
Amulya E, Sikder A, Vambhurkar G, Shah S, Khatri DK, Raghuvanshi RS, et al. Nanomedicine based strategies for oligonucleotide traversion across the blood-brain barrier. J Control Release. 2023;354:554-71.
Alhodieb FS, Rahman MA, Barkat MA, Alanezi AA, Barkat HA, Hadi HA, et al. Nanomedicine-driven therapeutic interventions of autophagy and stem cells in the management of Alzheimer's disease. Nanomedicine (Lond). 2023;18(2):145-68.
Albarqi HA, Garg A, Ahmad MZ, Alqahtani AA, Walbi IA, Ahmad J. Recent Progress in Chitosan-Based Nanomedicine for Its Ocular Application in Glaucoma. Pharmaceutics. 2023;15(2).
Akanchise T, Angelova A. Potential of Nano-Antioxidants and Nanomedicine for Recovery from Neurological Disorders Linked to Long COVID Syndrome. Antioxidants (Basel). 2023;12(2).
Ailioaie LM, Ailioaie C, Litscher G. Photobiomodulation in Alzheimer's Disease-A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine? Pharmaceutics. 2023;15(3).
Ailioaie LM, Ailioaie C, Litscher G. Synergistic Nanomedicine: Photodynamic, Photothermal and Photoimmune Therapy in Hepatocellular Carcinoma: Fulfilling the Myth of Prometheus? Int J Mol Sci. 2023;24(9).
Ahmad J, Garg A, Mustafa G, Mohammed AA, Ahmad MZ. 3D Printing Technology as a Promising Tool to Design Nanomedicine-Based Solid Dosage Forms: Contemporary Research and Future Scope. Pharmaceutics. 2023;15(5).
Ahmad A, Rashid S, Chaudhary AA, Alawam AS, Alghonaim MI, Raza SS, et al. Nanomedicine as potential cancer therapy via targeting dysregulated transcription factors. Semin Cancer Biol. 2023;89:38-60.
Agwa MM, Elmotasem H, Elsayed H, Abdelsattar AS, Omer AM, Gebreel DT, et al. Carbohydrate ligands-directed active tumor targeting of combinatorial chemotherapy/phototherapy-based nanomedicine: A review. Int J Biol Macromol. 2023;239:124294.
Adekiya TA, Owoseni O. Emerging frontiers in nanomedicine targeted therapy for prostate cancer. Cancer Treat Res Commun. 2023;37:100778.
Aalhate M, Mahajan S, Singh H, Guru SK, Singh PK. Nanomedicine in therapeutic warfront against estrogen receptor-positive breast cancer. Drug Deliv Transl Res. 2023;13(6):1621-53.
Zhou Q, Li J, Xiang J, Shao S, Zhou Z, Tang J, et al. Transcytosis-enabled active extravasation of tumor nanomedicine. Adv Drug Deliv Rev. 2022;189:114480.
Zhao J, Zhang C, Wang W, Li C, Mu X, Hu K. Current progress of nanomedicine for prostate cancer diagnosis and treatment. Biomed Pharmacother. 2022;155:113714.
Zhao B, Chen S, Hong Y, Jia L, Zhou Y, He X, et al. Research Progress of Conjugated Nanomedicine for Cancer Treatment. Pharmaceutics. 2022;14(7).
Zhang Z, Zhou Y, Zhao S, Ding L, Chen B, Chen Y. Nanomedicine-Enabled/Augmented Cell Pyroptosis for Efficient Tumor Nanotherapy. Adv Sci (Weinh). 2022;9(35):e2203583.
Zhang Z, Dalan R, Hu Z, Wang JW, Chew NW, Poh KK, et al. Reactive Oxygen Species Scavenging Nanomedicine for the Treatment of Ischemic Heart Disease. Adv Mater. 2022;34(35):e2202169.
Youden B, Jiang R, Carrier AJ, Servos MR, Zhang X. A Nanomedicine Structure-Activity Framework for Research, Development, and Regulation of Future Cancer Therapies. ACS Nano. 2022;16(11):17497-551.
Yokel RA. Direct nose to the brain nanomedicine delivery presents a formidable challenge. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022;14(2):e1767.
Yang Y, Zhao T, Chen Q, Li Y, Xiao Z, Xiang Y, et al. Nanomedicine Strategies for Heating "Cold" Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC. Adv Sci (Weinh). 2022;9(28):e2202797.
Yamada Y, Sato Y, Nakamura T, Harashima H. Innovative cancer nanomedicine based on immunology, gene editing, intracellular trafficking control. J Control Release. 2022;348:357-69.
Yadav R, Pradhan M, Yadav K, Mahalvar A, Yadav H. Present scenarios and future prospects of herbal nanomedicine for antifungal therapy. J Drug Deliv Sci Technol. 2022;74:103430.
Xue X, Qu H, Li Y. Stimuli-responsive crosslinked nanomedicine for cancer treatment. Exploration (Beijing). 2022;2(6):20210134.
Xu Y, Chen A, Wu J, Wan Y, You M, Gu X, et al. Nanomedicine: An Emerging Novel Therapeutic Strategy for Hemorrhagic Stroke. Int J Nanomedicine. 2022;17:1927-50.
Xu XX, Chen SY, Yi NB, Li X, Chen SL, Lei Z, et al. Research progress on tumor hypoxia-associative nanomedicine. J Control Release. 2022;350:829-40.
Xu X, Wu Y, Qian X, Wang Y, Wang J, Li J, et al. Nanomedicine Strategies to Circumvent Intratumor Extracellular Matrix Barriers for Cancer Therapy. Adv Healthc Mater. 2022;11(1):e2101428.
Xu Q, Chen Y, Jin Y, Wang Z, Dong H, Kaufmann AM, et al. Advanced Nanomedicine for High-Risk HPV-Driven Head and Neck Cancer. Viruses. 2022;14(12).
Wu W, Pu Y, Shi J. Nanomedicine-enabled chemotherapy-based synergetic cancer treatments. J Nanobiotechnology. 2022;20(1):4.
Wilson B, Mukundan Geetha K. Nanomedicine to deliver biological macromolecules for treating COVID-19. Vaccine. 2022;40(29):3931-41.
Wei Q, Wu Y, Liu F, Cao J, Liu J. Advances in antitumor nanomedicine based on functional metal-organic frameworks beyond drug carriers. J Mater Chem B. 2022;10(5):676-99.
Wang Y, Wang W, Kong F, Zhang Q, Xiao J, Zhang Y, et al. Tango of dual nanoparticles: Interplays between exosomes and nanomedicine. Bioeng Transl Med. 2022;7(2):e10269.
Wang X, Hua P, He C, Chen M. Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicine. Acta Pharm Sin B. 2022;12(9):3567-93.
Wang L, Xu H, Weng L, Sun J, Jin Y, Xiao C. Activation of cancer immunotherapy by nanomedicine. Front Pharmacol. 2022;13:1041073.
Wang H, Wang D, Yu J, Zhang Y, Zhou Y. Applications of metal-phenolic networks in nanomedicine: a review. Biomater Sci. 2022;10(20):5786-808.
Villa Nova M, Lin TP, Shanehsazzadeh S, Jain K, Ng SCY, Wacker R, et al. Nanomedicine Ex Machina: Between Model-Informed Development and Artificial Intelligence. Front Digit Health. 2022;4:799341.
Viegas C, Pereira DSM, Fonte P. Insights into Nanomedicine for Head and Neck Cancer Diagnosis and Treatment. Materials (Basel). 2022;15(6).
Vambhurkar G, Amulya E, Sikder A, Shah S, Famta P, Khatri DK, et al. Nanomedicine based potentially transformative strategies for colon targeting of peptides: State-of-the-art. Colloids Surf B Biointerfaces. 2022;219:112816.
Tawfik M, Chen F, Goldberg JL, Sabel BA. Nanomedicine and drug delivery to the retina: current status and implications for gene therapy. Naunyn Schmiedebergs Arch Pharmacol. 2022;395(12):1477-507.
Tang Z, Fan X, Chen Y, Gu P. Ocular Nanomedicine. Adv Sci (Weinh). 2022;9(15):e2003699.
Tan RSL, Hassandarvish P, Chee CF, Chan LW, Wong TW. Chitosan and its derivatives as polymeric anti-viral therapeutics and potential anti-SARS-CoV-2 nanomedicine. Carbohydr Polym. 2022;290:119500.
Taina-González L, de la Fuente M. The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA. Pharmaceutics. 2022;14(2).
Tagde P, Najda A, Nagpal K, Kulkarni GT, Shah M, Ullah O, et al. Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management. Int J Mol Sci. 2022;23(5).
Sun R, Dai J, Ling M, Yu L, Yu Z, Tang L. Delivery of triptolide: a combination of traditional Chinese medicine and nanomedicine. J Nanobiotechnology. 2022;20(1):194.
Sudheesh MS, Pavithran K, M S. Revisiting the outstanding questions in cancer nanomedicine with a future outlook. Nanoscale Adv. 2022;4(3):634-53.
Stavrou A, Ortiz A. Extracellular Vesicles: A Novel Tool in Nanomedicine and Cancer Treatment. Cancers (Basel). 2022;14(18).
Souri M, Soltani M, Moradi Kashkooli F, Kiani Shahvandi M, Chiani M, Shariati FS, et al. Towards principled design of cancer nanomedicine to accelerate clinical translation. Mater Today Bio. 2022;13:100208.
Sönksen M, Kerl K, Bunzen H. Current status and future prospects of nanomedicine for arsenic trioxide delivery to solid tumors. Med Res Rev. 2022;42(1):374-98.
Song Y, Ding Y, Dong CM. Stimuli-responsive polypeptide nanoassemblies: Recent progress and applications in cancer nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022;14(2):e1742.
Sivasubramanian M, Lin LJ, Wang YC, Yang CS, Lo LW. Industrialization's eye view on theranostic nanomedicine. Front Chem. 2022;10:918715.
Shukla A, Maiti P. Nanomedicine and versatile therapies for cancer treatment. MedComm (2020). 2022;3(3):e163.
Shi D, Feng C, Xie J, Zhang X, Dai H, Yan L. Recent progress of nanomedicine in secreted phospholipase A2 as a potential therapeutic target. J Mater Chem B. 2022;10(37):7349-60.
Shi D, Beasock D, Fessler A, Szebeni J, Ljubimova JY, Afonin KA, et al. To PEGylate or not to PEGylate: Immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives. Adv Drug Deliv Rev. 2022;180:114079.
Shevchenko KG, Garkushina IS, Canfarotta F, Piletsky SA, Barlev NA. Nano-molecularly imprinted polymers (nanoMIPs) as a novel approach to targeted drug delivery in nanomedicine. RSC Adv. 2022;12(7):3957-68.
Serov N, Vinogradov V. Artificial intelligence to bring nanomedicine to life. Adv Drug Deliv Rev. 2022;184:114194.
Saravanakumar K, Park S, Santosh SS, Ganeshalingam A, Thiripuranathar G, Sathiyaseelan A, et al. Application of hyaluronic acid in tissue engineering, regenerative medicine, and nanomedicine: A review. Int J Biol Macromol. 2022;222(Pt B):2744-60.
Saravanakumar K, Anbazhagan S, Pujani Usliyanage J, Vishven Naveen K, Wijesinghe U, Xiaowen H, et al. A comprehensive review on immuno-nanomedicine for breast cancer therapy: Technical challenges and troubleshooting measures. Int Immunopharmacol. 2022;103:108433.
Sarangi MK, Padhi S, Rath G, Nanda SS, Yi DK. Success of nano-vaccines against COVID-19: a transformation in nanomedicine. Expert Rev Vaccines. 2022;21(12):1739-61.
Sánchez-Molina S, Figuerola-Bou E, Sánchez-Margalet V, de la Cruz-Merino L, Mora J, de Álava Casado E, et al. Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies. Cancers (Basel). 2022;14(21).
Salvati A, Poelstra K. Drug Targeting and Nanomedicine: Lessons Learned from Liver Targeting and Opportunities for Drug Innovation. Pharmaceutics. 2022;14(1).
Saavedra-Leos MZ, Jordan-Alejandre E, Puente-Rivera J, Silva-Cázares MB. Molecular Pathways Related to Sulforaphane as Adjuvant Treatment: A Nanomedicine Perspective in Breast Cancer. Medicina (Kaunas). 2022;58(10).
Rout SK, Priya V, Setia A, Mehata AK, Mohan S, Albratty M, et al. Mitochondrial targeting theranostic nanomedicine and molecular biomarkers for efficient cancer diagnosis and therapy. Biomed Pharmacother. 2022;153:113451.
Rezaie J, Nejati V, Mahmoodi M, Ahmadi M. Mesenchymal stem cells derived extracellular vesicles: A promising nanomedicine for drug delivery system. Biochem Pharmacol. 2022;203:115167.
Ren X, Wang Y, Jia L, Guo X, He X, Zhao Z, et al. Intelligent Nanomedicine Approaches Using Medical Gas-Mediated Multi-Therapeutic Modalities Against Cancer. J Biomed Nanotechnol. 2022;18(1):24-49.
Ren J, Andrikopoulos N, Velonia K, Tang H, Cai R, Ding F, et al. Chemical and Biophysical Signatures of the Protein Corona in Nanomedicine. J Am Chem Soc. 2022;144(21):9184-205.
Raza F, Siyu L, Zafar H, Kamal Z, Zheng B, Su J, et al. Recent Advances in Gelatin-Based Nanomedicine for Targeted Delivery of Anti-Cancer Drugs. Curr Pharm Des. 2022;28(5):380-94.
Ramanunny AK, Wadhwa S, Gulati M, Vishwas S, Khursheed R, Paudel KR, et al. Journey of Alpinia galanga from kitchen spice to nutraceutical to folk medicine to nanomedicine. J Ethnopharmacol. 2022;291:115144.
Raghunathan S, Rayes J, Sen Gupta A. Platelet-inspired nanomedicine in hemostasis thrombosis and thromboinflammation. J Thromb Haemost. 2022;20(7):1535-49.
Quispe C, Herrera-Bravo J, Khan K, Javed Z, Semwal P, Painuli S, et al. Therapeutic applications of curcumin nanomedicine formulations in cystic fibrosis. Prog Biomater. 2022;11(4):321-9.
Quader S, Van Guyse JFR. Bioresponsive Polymers for Nanomedicine-Expectations and Reality! Polymers (Basel). 2022;14(17).
Quader S, Kataoka K, Cabral H. Nanomedicine for brain cancer. Adv Drug Deliv Rev. 2022;182:114115.
Qiao K, Xu L, Tang J, Wang Q, Lim KS, Hooper G, et al. The advances in nanomedicine for bone and cartilage repair. J Nanobiotechnology. 2022;20(1):141.
Peng S, Xiao F, Chen M, Gao H. Tumor-Microenvironment-Responsive Nanomedicine for Enhanced Cancer Immunotherapy. Adv Sci (Weinh). 2022;9(1):e2103836.
Peña Q, Wang A, Zaremba O, Shi Y, Scheeren HW, Metselaar JM, et al. Metallodrugs in cancer nanomedicine. Chem Soc Rev. 2022;51(7):2544-82.
Pei Z, Chen S, Ding L, Liu J, Cui X, Li F, et al. Current perspectives and trend of nanomedicine in cancer: A review and bibliometric analysis. J Control Release. 2022;352:211-41.
Ahmadi K, Amali A, Saedi B, Dasdar S, Rashedi S, Kianfar N, et al. Evaluation of cephalometric indices in patients with obstructive sleep apnea in comparison with healthy individuals. Advances in Oral and Maxillofacial Surgery. 2022;5:100250.
Amali A, Erfanian R, Amirzargar B, Sadeghi M, Saedi B, Emami H, et al. Polysomnographic Findings Versus Degree of Obstruction During Drug-Induced Sleep Endoscopy and Muller’s Maneuver. Indian Journal of Otolaryngology and Head & Neck Surgery. 2023;75(4):2769-76.
Amirifard H, Jameie M, Akbarpour S, Haghighi KS, Shojaei M, Heidari R, et al. Sleep microstructure and clinical characteristics of patients with restless legs syndrome. Journal of Clinical Sleep Medicine. 2022;18(11):2653-61.
Behkar A, Amirifard H, Samadi S, Alemohammad ZB, Golkhandan AR, Heidari R, et al. Global practice of sleep medicine: Iran. Journal of Clinical Sleep Medicine. 2024;20(6):1009-15.
Erfanian R, Heidari R, Emami H, Amirzargar B. Sleep Medicine Evaluation in the Annual Patient Management Problem (PMP) Exam for Otolaryngology Residents. Indian Journal of Otolaryngology and Head & Neck Surgery. 2022:1-4.
Erfanian R, Heidari R, Najafi A, Amirzargar B. Trends for Publications of Sleep Medicine and Upper Airway Sleep Surgery in PubMed Central Data Base: A Quadratic Growth Prediction. Journal of Sleep sciences. 2022.
Erfanian R, Mohebbi M, Abdullah H, Sadeghniiat-Haghighi K, Najafi A, Heidari R, et al. Effect of Lidocaine-prilocaine Cream on Using CPAP Mask Amongst Patients Undergone PAPtitration Study for Obstructive Sleep Apnea: A Randomized Controlled Trial Study. Indian Journal of Otolaryngology and Head & Neck Surgery. 2024:1-6.
Heidari R, Amirzargar B. Cleft Lip and Palate Diagnosis and Surgical Intervention. Innovative Perspectives in Oral and Maxillofacial Surgery. 2021:421-31.
Heidari R, Erfaniyan R, Emami H, Heidari M. effect of multilevel surgery on post surgical pain, in patients with obstructive sleep apnoea. Sleep Medicine. 2022;100:S248.
Heidari R, Najafi A, Jahanbakhsh F, Erfanian R, Yazdani M. Validity and reliability of the Persian version of the Athens Insomnia Scale. concern.11:12.
Heidari R, Najafzadeh M, Erfaniyan R, Razmpa E, Emami H, Heidari M. Evaluation of Effective Factors on Pain in Patients Undergoing Sleep Apnea Surgery. Journal of Contemporary Medical Sciences. 2022;8(1).
Heidari R, Nikoee N, Hoseini MS, Najafi A, Amali A, Amirzargar B, editors. Comparison between polysomnography scoring of auto-analyzing software with trained technician. JOURNAL OF SLEEP RESEARCH; 2018: WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA.
Heidari R, Shamsadini A, Najafi A, Erfanian R. Identifying Affecting Factors on Acceptance with CPAP on the First Night of PAP Titration in Sleep Clinic on Patients with Obstructive Sleep Apnea. Iranian Journal of Otorhinolaryngology. 2023;35(131):303.
Najafi A, Ala M, Amali A, Hivechi N, Heidari R, Mokary Y. An Evaluation of Obstructive Sleep Apnea Patient’s Quality of life Following Continuous Positive Airway Pressure and Uvulopalatopharyngoplasty. Indian Journal of Otolaryngology and Head & Neck Surgery. 2024;76(1):753-7.
Nikoee N, Hoseini MS, Najafi A, Amali A, Amirzargar B, Heidari R. Exploration of Reliable Parameters Scored by Automated Analysis in Polysomnography. Journal of Sleep Sciences. 2018;3(3-4):90-4.
Panah ZE, Sharifi A, Zoafa S, Etemadi-Aleagha A, Sohrabpour S, Behzadi M, et al. Uvulopalatopharyngoplasty with and without modified thyrohyoid suspension for obstructive sleep apnea treatment: a randomized clinical trial. European Archives of Oto-Rhino-Laryngology. 2023;280(10):4677-85.
Saghezchi SA, Azad N, Heidari R, Jajarmi V, Abdi S, Abaszadeh H-A, et al. The Effect of Prenatal Exposure to 2.4 GHz Radio Frequency on the Histology and Expression of the osteocalcin and RUNX2 Gene of the Forelimb in an NMRI Mouse. Journal of Lasers in Medical Sciences. 2019;10(4):283.
Shabani M, Akbarpour S, Shojaei M, Nejad M, Sadeghniiat-Haghighi K, Heidari R, et al., editors. Discrepancy between self-perceived sleep characteristics and polysomnographic parameters amongst patients of a referral sleep clinic. JOURNAL OF SLEEP RESEARCH; 2022: WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA.
Shahbazi M, Heidari R, Tafakhori A, Samadi S, Nikeghbalian Z, Amirifard H, et al. The effects of atomoxetine and trazodone combination on obstructive sleep apnea and sleep microstructure: A double-blind randomized clinical trial study. Sleep Medicine. 2024;113:13-8.
Stevens MR, Ghasemi S, Tabrizi R. Innovative Perspectives in Oral and Maxillofacial Surgery: Springer Nature; 2021.
Khalafi-Nezhad A, Saadi MI, Noshadi N, Jalali H, Ahmadyan M, Kheradmand N, et al. Change in Programmed Death-1 and Inducible Costimulator Expression in Patients with Acute Myeloid Leukemia Following Chemotherapy and Its Cytogenetic Abnormalities. Galen Medical Journal. 2022;11:e2394-e.
Iravani Saadi M, Jiang M, Banakar M, Mardani Valandani F, Ahmadyan M, Rostamipour HA, et al. Are the Costimulatory Molecule Gene Polymorphisms (CTLA-4) Associated With Infection in Organ Transplantation? A Meta-Analysis. Cell Transplantation. 2023;32:09636897231151576.
Saadi MI, Ramzi M, Fooladivanda N, Afshinpour S, Ghahramani Z, Ahmadyan M, et al. Probiotics: Potential Benefits and Safety in Hematological Malignancies: Probiotics in Hematologic Cancers. Galen Medical Journal. 2024;13:e3149-e.
Saadi MI, Nikandish M, Ghahramani Z, Valandani FM, Ahmadyan M, Hosseini F, et al. miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options. Journal of the Egyptian National Cancer Institute. 2023;35(1):18.
Karimian S, Taheri F, Farrokhi M, Farrokhi M, Bayat Z, Zadeh SAM, et al. Digital Health and Wearable Technologies. Kindle. 2024;4(1):1-240.
Farrokhi M, Taheri F, Moeini A, Farrokhi M, Khouzani PJ, Ghadirzadeh E, et al. Artificial Intelligence for Drug Development, Personalized Prescriptions, and Adverse Event Prediction. Kindle. 2024;4(1):1-180.
Farrokhi M, Taheri F, Moeini A, Farrokhi M, Alireza MZS, Farahmandsadr M, et al. Artificial Intelligence for Remote Patient Monitoring: Advancements, Applications, and Challenges. Kindle. 2024;4(1):1-261.
Farrokhi M, Taheri F, Farrokhi M, Moeini A, Tooyserkani SH, Shahali A, et al. Anti-Aging Strategies to Prevent Diseases: Promoting Longevity and Optimal Health. Kindle. 2024;4(1):1-194.
Farrokhi M, Taheri F, Farrokhi M, Heydari Z, Darbani R, Salbi M, et al. Advancements and Innovations in Cancer Management: A Comprehensive Perspective. Kindle. 2024;4(1):1-161.
Farrokhi M, Taheri F, Farrokhi M, Emtiazi N, Talebi M, Akbari A, et al. Human and AI: Collaborative Medicine in the Age of Technology. Kindle. 2024;4(1):1-160.
Farrokhi M, Taheri F, Bayat Z, Damiri M, Farrokhi M, Ghadirzadeh E, et al. Role of Lifestyle Medicine in the Prevention and Treatment of Diseases. Kindle. 2024;4(1):1-219.
Farrokhi M, Taheri F, Adibnia E, Mehrtabar S, Rassaf Z, Tooyserkani SH, et al. The AI Diagnostician: Improving Medical Diagnosis with Artificial Intelligence. Kindle. 2024;4(1):1-219.
Farrokhi M, Khouzani SJ, Farrokhi M, Jalayeri H, Faranoush P, Babaei M, et al. Artificial Intelligence and Deep Learning for Screening and Risk Assessment of Cancers. Kindle. 2024;4(1):1-140.
